Semaglutide promote weight loss and help patients lose weight through mimicking the action of GLP-1, a hormone that regulates insulin secretion, inhibits glucagon release, and promotes feelings of fullness, ultimately leading to reduced food intake
The C max values for each treatment group 1110 430 ng/mL (S-0.6 mg 2-10), 3800 900 ng/mL (S-0.9 mg 2-10), and 4400 1200 ng/mL (S-1.2 mg 2-10) (Figure 4B, Table S2, S3)
GIP receptor activation enhances glucose-dependent insulin secretion, promotes adipose tissue lipid storage and adipokine secretion, and may potentiate GLP-1 effects on appetite
Sudden worsening of nausea after initially improving may indicate a medication interaction, underlying gastrointestinal condition, or dose-related issue that needs adjustment
Nikhil Das, MD